Amicus Therapeutics Inc. buy Cantor Fitzgerald
Start price
29.02.24
/
50%
€11.80
Target price
28.02.25
€20.36
Performance (%)
-24.15%
End price
01.03.25
€8.95
Summary
This prediction ended on 01.03.25 with a price of €8.95. The prediction for Amicus Therapeutics Inc. disappointed with a performance of -24.15%. Cantor_Fitzgerald has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Amicus Therapeutics Inc. | 0.714% | 0.714% | -22.099% |
iShares Core DAX® | -0.693% | 2.143% | 24.303% |
iShares Nasdaq 100 | -1.173% | 1.632% | 12.915% |
iShares Nikkei 225® | -1.388% | 2.138% | 7.771% |
iShares S&P 500 | -1.411% | 0.648% | 7.222% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $22.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
07.11.24
07.11.24
€19.47
07.11.25
07.11.25
-28.50%
09.10.25
09.10.25
Stopped prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.00
15.01.25
15.01.25
€20.29
15.01.26
15.01.26
-21.67%
09.10.25
09.10.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
20.09.24
20.09.24
€17.90
20.09.25
20.09.25
-29.50%
21.09.25
21.09.25